Application note: Human iPS cells modified with Edit-R™ CRISPR-Cas9 reagents
Modify the genome and modulate expression of genes within human iPS cells with Dharmacon™ Edit-R CRISPR reagents.
Induced pluripotent stem cells are a valuable research tool for their ability to be turned into virtually any cell type. With the advent of CRISPR-Cas9 researchers can modify the genome of the iPS cells and subsequently differentiate them to see the affect that the genomic modification has upon the differentiated cell type. Here we present the ability to modify the genome and modulate expression of genes within a human induced pluripotent stem (iPS) cell line with Dharmacon™ Edit-R CRISPR reagents.
Related content from this organisation
- Application note: 3D cell panel screens for drug discovery and development
- Webinar series: Considerations for successful CRISPR-based cell line engineering
- On-demand webinar: Leveraging advances in predesigned synthetic sgRNA for highly functional and specific CRISPR-Cas9 gene knockout
- Expert view: Why you should use 3D models for high-throughput drug development screens
- Article: Tips for successful editing in T cells